Trending...
- Tech Startup to Offer Up To 100% Funding Aid to Individuals for Covering Their Education or Travel Expenses
- Academic Search Engine Knobull Announces Easy Switch Campaign
- Massachusetts Innovation Network Announces Inaugural Global Innovation Showcase
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. ET.
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.
More on Boston Chron
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.
More on Boston Chron
- State Street Elects Julio Portalatin and John Rhea to Its Board of Directors
- AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Calvetta Phair, CEO of PEP Travel Group and Waldron McCritty, CEO of BE LUX, Alumni of ASCEND 2020, form teaming alliance to promote Luxury Hospitality
- Ameresco Announces Pricing of Public Offering of Class A Common Stock
- Bank on Boston partnership to support unbanked and underbanked Boston residents
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
Filed Under: Business
0 Comments
Latest on Boston Chron
- ConvergeOne and Evolve IP Enter Strategic Hospitality Partnership
- Home2 Suites by Hilton Tucson Airport Celebrates Topping Off - Tucson's Newest Extended-Stay Hotel
- Truthset and the ANA AIMM Release First of its Kind Multicultural Online Data Benchmarks
- SmartBear Completes Investment Transaction with Vista Equity Partners and Francisco Partners
- Mayor Walsh announces Bank on Boston partnership to support unbanked and underbanked Boston residents
- Julia Hair Tax Refund Season Flash Sale Week With Buy Now Pay Later
- The Best Virgin Hair Vendors 2021
- ACS Lawyer In Brooklyn Announces Dismissal of OCFS Case
- Boston: Mayor Walsh announces start of renovations to historic Roxbury Lenox Apartments
- Liquid Core® Gum Company announces TDA Boulder Creative Director Jonathan Schoenberg has joined its Advisory Board
- Missouri is 45th State to Approve Cambridge Mobile Telematics' Insurance Scoring Model
- myLAB Box Launches 16 New At-Home Tests, Offering Comprehensive Health Monitoring from the Comfort of Home
- Zilker Partners Acquires Growth Digital, Forming One-of-a-Kind Firm
- TribalVision Named a Winner in HubSpot's Q4 2020 Impact Awards
- Allurion Technologies Announces 5 Million Pound Challenge in Celebration of World Obesity Day
- California Boating Supply Company Danik Hook Launches New Product for 2021
- Whose Dreams Of Hell Are More Interesting, Politicians Or Popes?
- Tech Startup Mokusei Intelligence Announces the '$500 Press Challenge'
- Tech Startup to Offer Up To 100% Funding Aid to Individuals for Covering Their Education or Travel Expenses
- Sandline Welcomes IT Veteran Ralf Kaiser as CTO